Local view for "http://purl.org/linkedpolitics/eu/plenary/2000-03-30-Speech-4-100"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20000330.4.4-100"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
"My vote in this matter is in support of the need to ensure that the European Patent Office improves its procedures to prevent any patent being used in human cloning.
The University of Edinburgh’s application for this patent has nothing to do with cloning (cloning was considered impossible when the patent was filed!)
It is established and legitimate practice in both academic and biopharmaceutical research to genetically manipulate human cells in tissue culture. This has been done for many years and is a major method of learning how genes and cells function. It bears no relation to genetic manipulation of people or embryos. It is misleading to suggest that the object of this patent is to genetically manipulate humans. The University of Edinburgh have indicated their willingness to cooperate with any suitable modification of the patent.
It think it should be made clear that the potential application of this patent in human cells is to guide the production of particular cells that could be useful in transplantation therapy for conditions such as Parkinson’s disease, strokes, diabetes and heart failure.
This is what the Edinburgh research is about."@en1
|
| lpv:spokenAs | |
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples